|
1
|
Agarwal M, Anchan C, Shah M, Puri A and
Pai S: Limb salvage surgery for osteosarcoma: Effective low-cost
treatment. Clin Orthop Relat Res. 459:82–91. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee JA, Kim MS, Kim DH, Lim JS, Park KD,
Cho WH, Song WS, Lee SY and Jeon DG: Postoperative infection and
survival in osteosarcoma patients. Ann Surg Oncol. 16:147–151.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li X, Moretti VM, Ashana AO and Lackman
RD: Perioperative infection rate in patients with osteosarcomas
treated with resection and prosthetic reconstruction. Clin Orthop
Relat Res. 469:2889–2894. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shin DS, Weber KL, Chao EY, An KN and Sim
FH: Reoperation for failed prosthetic replacement used for limb
salvage. Clin Orthop Relat Res. 358:53–63. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gorelick MH, Owen WC, Seibel NL and Reaman
GH: Lack of association between neutropenia and the incidence of
bacteremia associated with indwelling central venous catheters in
febrile pediatric cancer patients. Pediatr Infect Dis J.
10:506–510. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hingorani P, Seidel K, Krailo M,
Mascarenhas L, Meyers P, Marina N, Conrad EU and Hawkins DS: Body
mass index (BMI) at diagnosis is associated with surgical wound
complications in patients with localized osteosarcoma: A report
from the Children's Oncology Group. Pediatr Blood Cancer.
57:939–942. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wirganowicz PZ, Eckardt JJ, Dorey FJ,
Eilber FR and Kabo JM: Etiology and results of tumor endoprosthesis
revision surgery in 64 patients. Clin Orthop Relat Res. 358:64–74.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pan KL, Chan WH, Ong GB, Premsenthil S,
Zulkarnaen M, Norlida D and Abidin Z: Limb salvage in osteosarcoma
using autoclaved tumor-bearing bone. World J Surg Oncol.
10:1052012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jeys LM, Grimer RJ, Carter SR, Tillman RM
and Abudu A: Post operative infection and increased survival in
osteosarcoma patients: Are they associated? Ann Surg Oncol.
14:2887–2895. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lascelles BD, Dernell WS, Correa MT,
Lafferty M, Devitt CM, Kuntz CA, Straw RC and Withrow SJ: Improved
survival associated with postoperative wound infection in dogs
treated with limb-salvage surgery for osteosarcoma. Ann Surg Oncol.
12:1073–1083. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sottnik JL, U'Ren LW, Thamm DH, Withrow SJ
and Dow SW: Chronic bacterial osteomyelitis suppression of tumor
growth requires innate immune responses. Cancer Immunol Immunother.
59:367–378. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Noor S, Thornormoethsson HS, Zervas CT, et
al: Limb versus life-the outcomes of osteosarcoma in Cambodia. Int
Orthop. 38:579–585. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ando K, Heymann MF, Stresing V, Mori K,
Rédini F and Heymann D: Current therapeutic strategies and novel
approaches in osteosarcoma. Cancers (Basel). 5:591–616. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jeon DG, Song WS, Kong CB, Cho WH, Cho SH,
Lee JD and Lee SY: Role of surgical margin on local recurrence in
high risk extremity osteosarcoma: A case-controlled study. Clin
Orthop Surg. 5:216–224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Prokuski L: Prophylactic antibiotics in
orthopaedic surgery. J Am Acad Orthop Surg. 16:283–293.
2008.PubMed/NCBI
|
|
18
|
Wiemann B and Starnes CO: Coley's toxins,
tumor necrosis factor and cancer research: A historical
perspective. Pharmacol Ther. 64:529–564. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Werneke U: A guide to using complementary
alternative medicines in cancer. Nurs Times. 101:32–35.
2005.PubMed/NCBI
|
|
20
|
Buddingh EP, Schilham MW, Ruslan SE,
Berghuis D, Szuhai K, Suurmond J, Taminiau AH, Gelderblom H, Egeler
RM, Serra M, et al: Chemotherapy-resistant osteosarcoma is highly
susceptible to IL-15-activated allogeneic and autologous NK cells.
Cancer Immunol Immunother. 60:575–586. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thomas-Tikhonenko A and Hunter CA:
Infection and cancer: The common vein. Cytokine Growth Factor Rev.
14:67–77. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Buddingh EP, Ruslan SE, Berghuis D,
Gelderblom H, Anninga JK, Hogendoorn PC, Egeler RM, Schilham MW and
Lankester AC: Intact interferon signaling in peripheral blood
leukocytes of high-grade osteosarcoma patients. Cancer Immunol
Immunother. 61:941–947. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Whelan JS, Bielack SS, Marina N, et al:
EURAMOS-1, an international randomised study for osteosarcoma:
Results from pre-randomisation treatment. Ann Oncol. 26:407–414.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
De Palma M, Mazzieri R, Politi LS, Pucci
F, Zonari E, Sitia G, Mazzoleni S, Moi D, Venneri MA, Indraccolo S,
et al: Tumor-targeted interferon-alpha delivery by Tie2-expressing
monocytes inhibits tumor growth and metastasis. Cancer Cell.
14:299–311. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Galdiero MR, Bonavita E, Barajon I,
Garlanda C, Mantovani A and Jaillon S: Tumor associated macrophages
and neutrophils in cancer. Immunobiology. 218:1402–1410. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Matsushima H, Geng S, Lu R, Okamoto T, Yao
Y, Mayuzumi N, Kotol PF, Chojnacki BJ, Miyazaki T, Gallo RL, et al:
Neutrophil differentiation into a unique hybrid population
exhibiting dual phenotype and functionality of neutrophils and
dendritic cells. Blood. 121:1677–1689. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Geng S, Matsushima H, Okamoto T, Yao Y, Lu
R, Page K, Blumenthal RM, Ward NL, Miyazaki T and Takashima A:
Emergence, origin, and function of neutrophil-dendritic cell
hybrids in experimentally induced inflammatory lesions in mice.
Blood. 121:1690–1700. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Haen SP, Pereira PL, Salih HR, Rammensee
HG and Gouttefangeas C: More than just tumor destruction:
Immunomodulation by thermal ablation of cancer. Clin Dev Immunol.
2011:1602502011. View Article : Google Scholar : PubMed/NCBI
|
